Malte Kircher

Oberdürrbacher Str. 6
Wuerzburg, BY 97078, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 69 publications

FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study.

FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study.

Journal: Acta neuropathologica

Published: September 20, 2025

FAPi-PET/CT as surrogate marker for subclinical myocardial fibrosis is a prognostic tool for patients undergoing left-sided heart valve surgery.

FAPi-PET/CT as surrogate marker for subclinical myocardial fibrosis is a prognostic tool for patients undergoing left-sided heart valve surgery.

Journal: EJNMMI research

Published: May 28, 2025

Biodistribution and Radiation Dosimetry of [68Ga]Ga-RAYZ-8009, a Glypican 3-Targeting Compound for Imaging of Hepatocellular Carcinoma.

Biodistribution and Radiation Dosimetry of [68Ga]Ga-RAYZ-8009, a Glypican 3-Targeting Compound for Imaging of Hepatocellular Carcinoma.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: April 25, 2025

Feasibility of Short-Term Redifferentiation in Patients with Radioactive Iodine-Refractory Metastatic Thyroid Cancer.

Feasibility of Short-Term Redifferentiation in Patients with Radioactive Iodine-Refractory Metastatic Thyroid Cancer.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: March 30, 2025

Cardiac risk in recovered Covid-19 patients evaluated by 123I-mIBG.

Cardiac risk in recovered Covid-19 patients evaluated by 123I-mIBG.

Journal: Scientific reports

Published: March 24, 2025

[ 18 F]FDG PET/CT in Primary Angiosarcoma of the Thyroid.

[ 18 F]FDG PET/CT in Primary Angiosarcoma of the Thyroid.

Journal: Clinical nuclear medicine

Published: March 08, 2025

Biodistribution and Radiation Dosimetry for [68Ga]Ga-LNTH-1363S, a Probe Targeting Fibroblast Activation Protein α.

Biodistribution and Radiation Dosimetry for [68Ga]Ga-LNTH-1363S, a Probe Targeting Fibroblast Activation Protein α.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: February 27, 2025

CCK2 Receptor Ligand [68Ga]Ga-DOTA-CCK-66 PET/CT Outperforms [68Ga]Ga-DOTATOC PET/CT in a Patient with Small Cell Lung Cancer.

CCK2 Receptor Ligand [68Ga]Ga-DOTA-CCK-66 PET/CT Outperforms [68Ga]Ga-DOTATOC PET/CT in a Patient with Small Cell Lung Cancer.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: November 21, 2024

[99mTc]-PentixaTec SPECT/CT for Imaging of Chemokine Receptor 4 Expression After Myocardial Infarction.

[99mTc]-PentixaTec SPECT/CT for Imaging of Chemokine Receptor 4 Expression After Myocardial Infarction.

Journal: Circulation. Cardiovascular imaging

Published: November 13, 2024

Intense FAP Expression of Ovarian Metastatic Breast Cancer Detected by [ 68 Ga]RTX-1363 PET/CT.

Intense FAP Expression of Ovarian Metastatic Breast Cancer Detected by [ 68 Ga]RTX-1363 PET/CT.

Journal: Clinical nuclear medicine

Published: August 02, 2024

Biodistribution and Radiation Dosimetry for 68 Ga-DOTA-CCK-66, a Novel CCK 2 R-Targeting Compound for Imaging of Medullary Thyroid Cancer.

Biodistribution and Radiation Dosimetry for 68 Ga-DOTA-CCK-66, a Novel CCK 2 R-Targeting Compound for Imaging of Medullary Thyroid Cancer.

Journal: Clinical nuclear medicine

Published: August 02, 2024

Experience of rescue therapy with [177Lu]Lu-rhPSMA-10.1 in patients with primary or acquired resistance to [177Lu]Lu-PSMA-I&T.

Experience of rescue therapy with [177Lu]Lu-rhPSMA-10.1 in patients with primary or acquired resistance to [177Lu]Lu-PSMA-I&T.

Journal: European journal of nuclear medicine and molecular imaging

Published: July 22, 2024

Showing 1-12 of 69

Last Updated: 09/26/2026